Dialysis

PHILADELPHIA — Patients with kidney disease who opted to withdraw from dialysis typically survived around 1 week, according to data presented at ASN Kidney Week.

PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.

PHILADELPHIA — The protective effect of peer mentorship to reduce hospitalizations and ED visits in patients on maintenance dialysis may be population-specific, according to a study presented at ASN Kidney Week.

PHILADELPHIA — In a clinical trial, patients placed on home hemodialysis four times a week showed improved outcomes over in-center treatment using the Quanta Dialysis System, according to data presented here at ASN Kidney Week.

PHILADELPHIA — Improvements in access to transplant, workforce issues and the impact of dialysis treatments on the environment have been a focus for the American Society of Nephrology in the past year, the outgoing ASN president said here.

Most patients with severe chronic limb-threatening ischemia treated with a transcatheter deep venous arterialization system achieved limb salvage at 12 months, according to new data from the PROMISE II trial.

CMS has released a final rule for the prospective payment system that increases the Medicare bundled payment rate for dialysis treatments by 2.1% in 2024, up from a 1.6% increase proposed in June.

Fresenius Medical Care is recalling some 2008 Series hemodialysis machines because non-dioxin-like polychlorinated biphenyl acid may be leaching from the silicone tubing used in the machines, according to an FDA press release.

Brief dialysis may lead to better outcomes for patients with AKI on outpatient hemodialysis, according to recently published data from researchers at the University of California, San Francisco.

The FDA has set a user fee goal date of March 27, 2024, for review of the oral hypoxia-inducible factor prolyl hydroxylase inhibitor vadadustat for the treatment of anemia in adults on dialysis.